Washington: Researchers including an Indian origin have shed some light on why aspirin benefits some people and not others.Researchers at Duke Medicine developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy.The study showed that the new gene expression profile not only measures the effectiveness of aspirin, but also serves as a strong predictor of patients who are at risk for heart attack.The Duke researchers enlisted three groups of participants - two of healthy volunteers and one comprised of patients with heart disease seen in outpatient cardiology practices.
Narendra Modi`s 17-point agenda for the nation
Power outage looms large as coal stocks dry
Bangalore rape case: NHRC slaps notice on govt
Don`t take us for granted, NCP warns Congress